Will CPIX, DPRO, SIEB, QLGN go up tomorrow?

The deep research logic is organized as follows: 

Okay, let's tackle this question. The user is asking if CPIX, DPRO, SIEB, and QLGN will go up tomorrow. First, I need to check the references provided to gather relevant data for each stock.

Starting with CPIX. The earnings release date is August 5, 2025 . The current price trend is bearish with a duration of 27 days . The support and resistance levels are between 2.04 and 5.94 . The forecast suggests a swing trend with a hold advice . The trend similarity forecast shows a mean price of around $3.85 with a 12.36% expected max gain . However, the stock closed at $3.71 on July 17, 2025, with a -4.38% change . There's also news about insider buying and technical breakouts [^5, ^6, ^8]. The company has a market cap of $44.8M and recent revenue growth [^5, ^6, ^7]. The price is near the upper Bollinger band, indicating overextension . The user is interested in high-growth, undervalued stocks, so CPIX might fit if the breakout happens.

Next, DPRO. Earnings are on August 12 or 13 . The stock surged 39.38% on July 17 to $7.22 . They secured a DoD contract for their Commander3 XL drone [^10-13]. Analysts raised the price target to $6 from $3.50 . The stock is in a bullish trend with a 36.73% upside forecast . The user likes UAV and defense stocks, so DPRO seems promising. However, the high volatility and recent surge might indicate short-term risks.

SIEB has earnings on August 13 . The stock closed at $4.04 with a 6.32% gain . They were added to the Russell 2000 index [^17, ^33], which could bring institutional capital. The company launched a "Generation Wealth" campaign targeting Gen Z [^14-16]. The price target is around $4.69 with a 3.95% ROI . However, some forecasts predict a decline . The user is interested in fintech and defense, so SIEB's inclusion in Russell and their tech initiatives might be attractive.

QLGN's earnings are on August 13 . The stock dropped 17.05% to $3.26 . They secured global patents for QN-302 [^19-22, ^46, ^47], leading to a surge in price [^20, ^21]. The forecast shows a high upside potential with a 445.74% rise . However, the recent drop might indicate profit-taking after the patent news. The user likes biotech and high-growth stocks, so QLGN could be a candidate if the patents drive future growth.

Putting it all together, the user prefers medium to long-term investments with high growth potential. CPIX has a breakout potential but is bearish. DPRO is in a strong uptrend with defense contracts. SIEB has institutional backing but mixed forecasts. QLGN has high upside but recent volatility. The conclusion should highlight which stocks align best with the user's interests and risk tolerance.

### 🌟 **Conclusion**
Based on the latest data and market dynamics, **CPIX, DPRO, and SIEB show higher potential for upside movement tomorrow**, while **QLGN faces near-term risks despite long-term growth prospects**. Here’s the breakdown:

---

### 📊 **Analysis by Stock**

#### **1. CPIX (Cumberland Pharmaceuticals)**
- **Key Data**:
- **Earnings Release**: August 5, 2025 .
- **Price Trend**: Bearish (27-day duration), with a 40% chance of trend continuation .
- **Support/Resistance**: Current price ($3.71) between narrow support ($3.00) and resistance ($5.90) .
- **Forecast**: 12.36% upside potential, but 20.08% downside risk .
- **Recent News**: Insider buying ($1.2M) and technical breakout above $3.50 [^5, ^6].

- **Conclusion**: CPIX is in a critical breakout zone. If it closes above $3.80 (narrow resistance), it could surge. However, bearish momentum and high volatility make it a **medium-risk play**.

---

#### **2. DPRO (Draganfly)**
- **Key Data**:
- **Earnings Release**: August 12, 2025 .
- **Price Trend**: Bullish (39.38% surge to $7.22 on July 17) .
- **Market Catalyst**: DoD contract for Commander3 XL drones [^10-13].
- **Analyst Take**: Price target raised to $6 (from $3.50), with 36.73% upside [^27, ^30].

- **Conclusion**: DPRO is a **high-growth, high-risk stock**. The DoD contract and institutional interest (Russell 2000 inclusion) suggest further upside. However, extreme volatility (74.15% daily swing) requires caution.

---

#### **3. SIEB (Siebert Financial)**
- **Key Data**:
- **Earnings Release**: August 13, 2025 .
- **Price Trend**: Bullish (6.32% gain to $4.04 on July 17) .
- **Market Catalyst**: Russell 2000 inclusion and $50M ATM offering for tech initiatives [^17, ^33].
- **Forecast**: 3.95% ROI in July , but mixed signals (bullish/bearish moving averages) .

- **Conclusion**: SIEB is a **balanced play** with institutional backing and tech-driven growth. However, short-term resistance at $4.39 (50-day MA) could cap gains.

---

#### **4. QLGN (Qualigen Therapeutics)**
- **Key Data**:
- **Earnings Release**: August 13, 2025 .
- **Price Trend**: Bearish (-17.05% drop to $3.26 on July 17) .
- **Market Catalyst**: Global patents for QN-302 (25 countries) [^19-22].
- **Forecast**: 445.74% upside potential by 2025 , but recent profit-taking pressure .

- **Conclusion**: QLGN is a **high-risk, high-reward stock**. The patent news is bullish, but near-term volatility and lack of clinical data (Phase 1 trials) make it speculative.

---

### 🎯 **Final Take**
- **Best Bet**: **DPRO** (DoD contract, high growth potential).
- **Second Choice**: **SIEB** (institutional inflows, tech focus).
- **Risky Play**: **CPIX** (breakout risk vs. bearish momentum).
- **Hold**: **QLGN** (patent-driven upside, but high volatility).

Let me know if you’d like a deeper dive into any of these! 🚀